{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T08:56:31Z","timestamp":1785488191912,"version":"3.56.0"},"reference-count":36,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T00:00:00Z","timestamp":1285804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[2011,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Children with classic galactosemia are at risk for motor speech disorders resulting from disruptions in motor planning and programming (childhood apraxia of speech or CAS) or motor execution (dysarthria). In the present study of 33 children with classic galactosemia, 21% were diagnosed with CAS, 3% with ataxic dysarthria, and 3% with mixed CAS\u2010dysarthria. Voice disorders due to laryngeal insufficiency were common in children with dysarthria and co\u2010occurred with CAS. Most (58%) of the children with classic galactosemia had decreased respiratory\u2010phonatory support for speech, and 33% had disturbed vocal quality that was indicative of cerebellar dysfunction. Three children, two diagnosed with CAS and one not diagnosed with a motor speech disorder, had vocal tremors. Treatment of voice dysfunction in neurogenic speech disorders is discussed.<\/jats:p>","DOI":"10.1007\/s10545-010-9213-4","type":"journal-article","created":{"date-parts":[[2010,9,29]],"date-time":"2010-09-29T09:01:25Z","timestamp":1285750885000},"page":"377-385","source":"Crossref","is-referenced-by-count":25,"title":["Voice disorders in children with classic galactosemia"],"prefix":"10.1002","volume":"34","author":[{"given":"Nancy L.","family":"Potter","sequence":"first","affiliation":[{"name":"Department of Speech and Hearing Sciences Washington State University\u2010Spokane PO Box 1495 Spokane WA 99210\u20101495 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,9,30]]},"reference":[{"key":"e_1_2_6_2_1","unstructured":"American Speech\u2010Language\u2010Hearing Association(2007)Childhood apraxia of speech (technical report).www.asha.org\/policy."},{"key":"e_1_2_6_3_1","volume-title":"OWLS: listening comprehension scale and oral expression scale","author":"Carrow\u2010Woolfolk E","year":"1995"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1159\/000076061"},{"key":"e_1_2_6_5_1","unstructured":"DelaneyAL KentRD(2004)Developmental profiles of children diagnosed with apraxia of speech.Poster session presented at the annual convention of the American Speech\u2010Language\u2010Hearing Association Philadelphia PA."},{"key":"e_1_2_6_6_1","volume-title":"Motor speech disorders: substrates, differential diagnosis, and management","author":"Duffy JR","year":"2005"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-008-0806-0"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2008.11.052"},{"key":"e_1_2_6_9_1","volume-title":"Kaufman brief intelligence test","author":"Kaufman AS","year":"2004"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02143794"},{"key":"e_1_2_6_11_1","unstructured":"Kay Elemetrics(2003)Multi\u2010Dimensional Voice Program: software instruction manual.Pine Brook Kay Elemetrics."},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/0269920031000086248"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1044\/jslhr.4305.1275"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9924(03)00016-9"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0887-8994(92)90072-7"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1542\/peds.73.3.309","article-title":"Curious neurological sequelae in galactosemia","volume":"73","author":"Lo W","year":"1984","journal-title":"Pediatrics"},{"key":"e_1_2_6_17_1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/hbm.20859","article-title":"Neural correlates of efficacy of voice therapy in Parkinson's disease identified by performance\u2010correlation analysis","volume":"31","author":"Narayana S","year":"2009","journal-title":"Hum Brain Mapp"},{"key":"e_1_2_6_18_1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1542\/peds.88.2.346","article-title":"Verbal dyspraxia in treated galactosemia","volume":"88","author":"Nelson CD","year":"1991","journal-title":"Pediatrics"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-008-0817-x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1044\/0161-1461.2002.133"},{"key":"e_1_2_6_21_1","unstructured":"PotterNL JohnsonJM ShribergLD(2006)Speech and language characteristics of children with galactosemia.Poster session presented at the annual convention of the Symposium for Research in Child Language Disorders Madison WI."},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-008-0877-y"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/00222895.2009.10125919"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.71.4.493"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2005.02.015"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/00125817-200003000-00005"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1044\/1058-0360(2003\/085)"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1044\/1092-4388(2007\/064)"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02143813"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcomdis.2009.09.001"},{"key":"e_1_2_6_31_1","doi-asserted-by":"crossref","unstructured":"ShribergLD PotterNL StrandEA(2010)Prevalence and phenotype of childhood apraxia of speech in youth with galactosemia.J Speech Lang Hear R. (accepted)","DOI":"10.1044\/1092-4388(2010\/10-0068)"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1159\/000287212"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/026992099299211"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01800204"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(83)80292-3"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1203\/01.PDR.0000049666.19532.1B"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0271-5317(01)00401-8"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-010-9213-4","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1007\/s10545-010-9213-4","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-010-9213-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T20:52:16Z","timestamp":1711831936000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s10545-010-9213-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,30]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["10.1007\/s10545-010-9213-4"],"URL":"https:\/\/doi.org\/10.1007\/s10545-010-9213-4","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,30]]}}}